IMMUNITYBIO, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-96.4M | $-120.8M | $-236.9M | $-6.2M | $-2.0M |
| Depreciation & Amortization | $5.6M | $3.6M | $1.5M | $36.0K | $4.0K |
| Depreciation | $3.3M | $1.0M | $100.0K | $36.0K | — |
| Amortization | $2.3M | $2.6M | $1.3M | $0 | — |
| Stock-Based Compensation | $37.0M | $73.9M | $211.2M | $789.0K | $884.0K |
| Net Cash from Operating Activities | $-48.8M | $-38.6M | $-25.3M | $-5.4M | $-668.0K |
| Investing Activities | |||||
| Capital Expenditures | $34.8M | $6.6M | $2.2M | $235.0K | $3.0K |
| Business Acquisitions | $0 | $0 | $1.8M | $0 | — |
| Net Cash from Investing Activities | $99.6M | $-113.7M | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | $15.2M | $15.8M | $4.8M | $0 | — |
| Net Cash from Financing Activities | $-35.0M | $-15.6M | — | — | — |
| Net Change in Cash | $15.8M | $-167.8M | $116.8M | $58.8M | $234.0K |
| Free Cash Flow | $-83.6M | $-45.2M | $-27.5M | $-5.7M | $-671.0K |